Feb 23, 2026 08:30AM
Feb 23, 2026 08:30AM
Feb 12, 2026 04:01PM
Feb 3, 2026 06:44AM
Jan 30, 2026 08:31AM
Jan 30, 2026 08:30AM
Jan 12, 2026 07:31AM Ultragenyx reports preliminary 2025 revenue of $672-674 million
Jan 12, 2026 07:30AM
Jun 23, 2025 10:33AM
May 6, 2025 04:01PM
Feb 19, 2025 07:13AM
Feb 18, 2025 08:07AM
Feb 18, 2025 08:00AM
Feb 18, 2025 06:52AM Ultragenyx Pharma (RARE) PT Raised to $136 at Canaccord Genuity
Feb 14, 2025 06:57AM
Feb 13, 2025 04:01PM
Feb 5, 2025 08:00AM
Feb 5, 2025 08:00AM
Jan 13, 2025 05:22AM
Jan 12, 2025 11:00AM
May 15, 2023 09:10AM Key Biotech Events to Watch, Week of 5/15/2023
May 15, 2023 09:08AM
Jul 1, 2020 08:11AM
May 6, 2020 04:01PM
May 6, 2020 04:01PM
Feb 27, 2020 08:06AM
Feb 27, 2020 08:00AM
Feb 27, 2020 08:00AM Ultragenyx and Kyowa Kirin Announce FDA Acceptance and Priority Review Designation of Supplemental Biologics License Application for Crysvita® (burosumab) for Tumor-Induced Osteomalacia (TIO)
Feb 13, 2020 04:01PM
Feb 13, 2020 04:01PM
Jan 13, 2020 08:20AM
Jan 13, 2020 08:10AM
Jan 13, 2020 08:10AM
Nov 5, 2019 04:01PM
Nov 5, 2019 04:01PM Ultragenyx Reports Third Quarter 2019 Financial Results and Corporate Update
Oct 14, 2019 08:32AM
Oct 14, 2019 08:30AM
Oct 14, 2019 08:30AM
Feb 23, 2018 08:07AM
Feb 23, 2018 08:00AM
Feb 23, 2018 08:00AM
Feb 23, 2018 08:00AM Kyowa Kirin and Ultragenyx Announce Crysvita® (burosumab) Receives Conditional Marketing Authorisation in Europe for the Treatment of X-Linked Hypophosphatemia in Children
Feb 20, 2018 04:05PM
Feb 20, 2018 04:05PM
Dec 15, 2017 08:33AM
Dec 15, 2017 08:30AM
Dec 15, 2017 08:30AM
Dec 15, 2017 08:30AM
Nov 13, 2017 08:39AM Ultragenyx Pharma (RARE) PT Lowered to $51 at Bernstein
Nov 6, 2017 07:49AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All